home
companies
disclaimer
med safety app
RAFINLAR®
Capsules
scheduling status
S4
registration number
51/32.2/0817; 51/32.2/0818
What RAFINLAR® contains
RAFINLAR 50 mg contains 59.25 mg Dabrafenib mesylate equivalent to 50 mg of free base. RAFINLAR 75 mg contains 88.88 mg Dabrafenib mesylate equivalent to 75 mg of free base.
other ingredients
Hypromellose capsule: microcrystalline cellulose, magnesium stearate (vegetable source), colloidal silicon dioxide. Shell composition: red iron oxide, titanium dioxide, hypromellose. Monogramming: black iron oxide, shellac ammonium hydroxide.
Therapeutic classification
L01XE23.
Download Patient Info Leaflet
Download Professional Info
© 2026 SAHPRA. ALL RIGHTS RESERVED